Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Changes in operating assets and liabilities:
Net income (loss)	$ 19,727	$ (5,955)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	835	843
Gain on sales-type leases		(99)
Reversal of credit loss		10
Write down of inventories		98
Amortization of convertible notes	1,490
Gain on change in fair value of derivative liability	(589)
Share-based compensation	(17)	146
Impairment loss on goodwill	4,271
Warranty reserve	(586)	(23)
Amortization of right-of-use assets	470	491
Loss on warrants issued during private placement	7,432
Gain on change in fair value of warrant liability	(14,618)
Bargain purchase gain	(32,072)
Deferred tax liability reversal	(3,041)
Changes in operating assets and liabilities:
Accounts receivable	(3,205)	(271)
Inventories	12,854	2,002
Held-for-sale leased assets	413
Prepaid expenses and other assets	(441)	405
Accounts payable	1,115	672
Accrued liabilities	467	(2)
Deferred revenue	(10)	(17)
Advance from customers	2,309	420
Lease liabilities	(869)	(491)
Net investment in leases	111
Amount due from related party	46	93
Income tax payable	2,309
Net cash used in operating activities	(1,599)	(1,678)
Cash flows from investing activities:
Purchase of property and equipment	(113)	(766)
Loan lent to a related party	(816)	(400)
Proceeds from repayment from a related party	50	400
Acquisition of Proterra	(10,000)
Net cash used in investing activities	(10,879)	(766)
Cash flows from financing activities:
Repayment of borrowings	(2,008)	(4)
Proceeds from borrowings		1,464
Proceeds from borrowings	2,363
Repayment of related party borrowings	(1,904)
Proceeds from related party borrowings	1,041
Proceeds received from private placements	11,104
Proceeds received from standby equity purchase agreement		1,227
Net cash generated from financing activities	10,596	2,687
(Decrease) increase in cash, cash equivalents and restricted cash	(1,882)	243
Cash, cash equivalents and restricted cash at beginning of the period	3,283	389
Cash, cash equivalents and restricted cash at end of the period	1,401	632
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents	1,401	382
Restricted Cash, Current		250
Total cash, cash equivalents, and restricted cash	1,401	632
Supplemental cash flow information:
Income tax paid
Non-cash activities:
Derivative liabilities recorded as debt discount		294
Issuance of common stock per convertible note conversion	832
Reclass of derivative liability to additional paid-in capital upon conversion of related convertible debentures	273
Issuance of restricted shares to Wisdom Financial to repay the consulting fee	270
Issuance of common stock for settlement with vendors	1,693
Inventories transferred to property and equipment		$ 270